Skip to main content

Table 3 Patient reactions to psychiatrist’s offer of long-acting injectable antipsychotic treatment

From: Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia

LAI-naïve patient reactions to n (%) Prescribed a LAI, n
LAI offer (n = 19)   (% of reaction category)
 Favorable 3 (16) 3 (100)
 Neutral/passive 9 (47) 6 (67)
 Unfavorable/concerned 7 (37) 2 (29)
Verbalized patient reasons for LAI acceptance (favorable) a , n
 Adherence benefits   3
 Extended/consistent efficacy   1
 Lessen oral pill burden   1
Verbalized patient reasons for LAI refusal (unfavorable) b , n
 Fear of needles   3
 Dosing logistics/administration   2
 Side effect concerns   2
 Unclear   1
  1. aTwo patients cited 1 other benefit in addition to adherence.
  2. bOne patient cited 2 reasons for refusal of LAI.
  3. LAI, long-acting injectable antipsychotic.